Dr. Pyle was formerly Chief Technical Officer and co-founder of Epoc, Inc., a privately held medical engineering company. Dr. Pyle holds an appointment as adjunct professor of bioengineering at Vanderbilt University where he has worked to develop cross-disciplinary programs of biological and engineering research. As the co-founder and Chief Technical Officer of Pria Diagnostics, Dr. Pyle was named Innovator of the Year (2006) by Frost and Sullivan. Dr. Pyle holds numerous pending and issued patents in the engineering and biological sciences and has worked in diverse cross-discipline areas such as nanofabrication, optical engineering, and structural biology.
In addition to his broad technical abilities, Dr. Pyle has established numerous corporate partnerships between small technical companies and some of the world’s largest corporations. He has directly supervised and coordinated both business development and operational activities within large co-development partnerships. Dr. Pyle has worked in finance, technical and manufacturing transactions in Singapore, Japan, and China. His post-doctoral research focused on the large-scale expression and control of neural proteins. He holds a Ph.D. in Molecular and Cellular Physiology and an M.D. from Stanford University. He received degrees in optical engineering and physics from the University of Arizona.
Cynthia (C.J.) Warner joined Sapphire Energy in February 2009 as President. She brings more than 27 years of experience in the energy, refining and transportation industries. At Sapphire Energy, Ms. Warner is tasked with driving the company’s initiative to transition technology trials and research into commercial-scale crude oil operations. Using only sunlight, CO2 and non-potable water, Sapphire Energy’s production of Green Crude is the environmental and economically wiser renewable option for replacing petro-based gasoline, diesel and jet fuel.
A chemical engineer by training and one of the very few senior women in the oil and gas industry, Ms. Warner served as an executive with energy industry giants British Petroleum, Amoco Oil Company and UOP. Prior to joining Sapphire, she most recently served as Group Vice President, Global Refining for BP where she was instrumental in turning around BP’s US refining business and achieving record performance in International refining. During her 10-year career with BP she held numerous leadership roles including overseeing refining operations in five continents and developing long-term technology strategies for low carbon and sustainable fuels. Ms. Warner led the groundbreaking cooperative effort with the US EPA to shape a framework for Clean Air improvements which was eventually signed on by the entire US Refining industry.
Ms. Warner began her career at UOP where she had significant hands-on experience learning refining process operations. That was followed by several years at Amoco where she held key operational leadership roles. She is a featured leader in the 2008 book ‘Becoming a Resonant Leader: Develop Your Emotional Intelligence′ (Harvard Business School Press).
Ms. Warner has a BS degree in Chemical Engineering from Vanderbilt University and an MBA from Illinois Institute of Technology.
Jim Lambright joined Sapphire Energy after a distinguished career in the global financial arena. He was most recently the President & Chairman of the Board of the U.S. Export-Import Bank, the independent government corporation responsible for financing American exports to over 150 countries. Having taken the helm of Ex-Im Bank in 2005 after holding a series of staff and management positions, Jim oversaw a $60 billion credit portfolio of project and export finance transactions. Under Jim’s leadership, Ex-Im Bank became a self-financing institution operating without taxpayer funds. Jim served as a principal participant in the first five meetings of the U.S.-China Strategic Economic Dialogue initiated by President Hu and President Bush in 2006.
At the peak of the global financial crisis in the fall of 2008, United States Treasury Secretary Paulson asked Jim to assume the role of Chief Investment Officer the U.S. Treasury Department’s $700 billion Troubled Asset Relief Program (TARP). There, he executed and managed TARP investments to optimize returns and prevent the collapse of the financial system. Jim and his team engineered investments in over 600 institutions, including the country’s largest banks, insurers, and auto manufacturers. Jim maintained his role at Ex-Im Bank during this time, and at the request of Treasury Secretary Geithner, Jim stayed on to facilitate a smooth transition to the Obama administration.
Mr. Lambright has successfully led organizations through the challenges lying at the intersection of finance, global markets, government, and a breadth of industries. He has been responsible for the successful completion of over $400 billion in financial transactions.
Jim Lambright began his career in private equity at Donaldson, Lufkin & Jenrette (later Credit Suisse) after receiving degrees from Stanford University and Harvard Law School.
Mr. Mendez has held a number of top industry positions at the forefront of the molecular biology revolution. In addition to serving as Director of Bioengineering at GenWay, Mr. Mendez was also associate director of Exploratory Research at Syrrx, Inc. (presently Takeda Pharmaceuticals). There he established a new department that focused on novel platforms for over-expression, purification, and crystallization of membrane proteins. Mr. Mendez co-founded and led the technical program at MemRx, a structural biology company that focused on the structure determination of membrane proteins, specifically GPCRs. Mr. Mendez is widely regarded as one of the lead pioneers in the development of fully human antibodies and is the lead author and co-inventor of the Xenomouse platform technology that formed Abgenix, Inc., most recently acquired by Amgen for $2.2 billion. He created all the viral vectors for the Cell Genesys Platform technology, GVAX. Mr. Mendez has served as a genetic consultant and scientific adviser for numerous biotech and academic institutions, including Geron Corporation, Gentrol, Inc., Expression Systems, Aliva, Inc., and the California Institute of Technology. He is also the founder and principal scientist of Gryffin Consulting, Inc., a genetic engineering consulting firm specializing in the areas of gene therapy and antibody and membrane protein production.
Dr. Aravanis has over ten years of R&D experience developing products at the interface of engineering and biology. He was a pioneer in developing the first biological applications of micro-electromechanical systems (MEMS), microfluidics, and polymer optics. He has held R&D positions at Stanford University, Hewlett Packard, Lawrence Berkeley Laboratories, and Pria Diagnostics, where he was a co-founder and the Vice President of Engineering. While there, he led the R&D team that developed Pria's disposable diagnostic system, which has been licensed world-wide. Dr. Aravanis received his M.D. and Ph.D. in Electrical Engineering from Stanford University where he was a fellow of the Helen Hay Whitney Foundation, the Walter V. and Idun B. Berry Foundation, the National Science Foundation, Stanford University, and the NIH. He has authored numerous peer-reviewed journal articles and conference proceedings, is an inventor on issued and pending patents, and has presented his work in seminars at Stanford University, UC Berkeley, MIT, Oxford, and The Society for Neuroscience.
Tim Zenk has spent much of his distinguished career shaping public policy – in helping leaders become better leaders and the public become more educated about key issues impacting the nation and the globe. His more than 20 years of rich experience has taken him from the front lines of Washington D.C., to the back roads of the Middle East, and to rural areas working on big issues in small towns. His passion is apparent and his experience varied. Most recently, as executive vice president for Edelman, an international communications firm, he built and led numerous campaigns, organized public-private partnerships, and counseled energy, biotech and technology leaders. Some clients included Louis Dreyfus Commodities, NorthernStar Natural Gas, Fate Therapeutics and Ikaria. Prior to that, he was founder and vice president of Chameleon Technology, a venture funded cutting-edge leader in wireless infrastructures. He also was a top executive for Telecommunications Systems (NYSE - TSYS), a leading provider of mission critical wireless data systems for wireless carriers, governments and intelligence organizations.
Tim is known nationally for his political acumen, particularly regarding his work on key campaigns ranging from gubernatorial to congressional to presidential. His global work for the Clinton/Gore administration has left him with professional and life experiences that will last forever. Today, his passion for legacy energy solutions are top on his agenda and he is working to help Sapphire be the foremost leader in solving one of today’s biggest environmental, economic and political quandaries – energy dependence.
He is an avid fisherman and science junkie. His favorite channel is sci-fi where he frequently gets confused as to whether the aliens are real or not.
Peter Attia came to Sapphire Energy from McKinsey & Company, where he was a consultant in the Palo Alto office as a member of the corporate risk and healthcare practices. Prior to arriving at McKinsey, Peter spent 5 years at the Johns Hopkins Hospital in Baltimore, Maryland as a general surgery resident, where he was the recipient of several prestigious awards and the author of a comprehensive review manual of general surgery. He also spent 2 years at the National Institutes of Health, in Bethesda, Maryland as a surgical oncology fellow at the National Cancer Institute.
The author of numerous medical and research papers, he earned his M.D. from Stanford University and holds a B.Sc. in Mechanical Engineering and Applied Mathematics from Queen’s University in Kingston, Ontario, Canada, where he also taught and helped revamp the calculus curriculum.
Jaime joined the Sapphire team in January 2009 . He leads Sapphire’s commercial development and engineering teams to plan, design and build the next generation of algae-to-energy farms in the United States and other globally strategic locations. He joins Sapphire Energy with more than 25 years of experience in the field of engineering where he managed the planning, design, construction and operations of many complex and noteworthy civil, environmental, transportation, water resources and energy projects. Prior to Sapphire Energy, Jaime served as Chief Operating Officer and Principal Engineer of AMEC Geomatrix, Inc., Managing Principal for AKM Consulting Engineers, and Engineering Manager for Church Engineering, Inc.. Jaime received his M.S. in Civil Engineering from Stanford University and a B.S. in Civil Engineering from the University of California, Berkeley. He is a Registered Civil Engineer and a Member of the American Society of Civil Engineers.